Skip to main content
Sekwon Jang, MD, Oncology, Fairfax, VA, Inova Fairfax Medical Campus

SekwonJangMD

Oncology Fairfax, VA

Assistant Professor, Medicine, Georgetown University School of Medicine

Dr. Jang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jang's full profile

Already have an account?

  • Office

    8081 Innovation Park Dr
    Level 5 - Chesapeake Clinic
    Fairfax, VA 22031
    Phone+1 571-472-1190
    Fax+1 571-472-1188
  • Is this information wrong?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2004 - 2007
  • Seoul National University College of Medicine
    Seoul National University College of MedicineClass of 2001

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2014 - 2024
  • DC State Medical License
    DC State Medical License 2010 - 2018
  • MD State Medical License
    MD State Medical License 2011 - 2018
  • MN State Medical License
    MN State Medical License 2009 - 2011
  • PA State Medical License
    PA State Medical License 2004 - 2007
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Paradigm Shift in the Management of High Risk Melanoma 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

  • Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
    Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage MelanomaJune 16th, 2020
  • Personalis, Inc. To Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33
    Personalis, Inc. To Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33November 9th, 2011

Other Languages

  • Korean

Hospital Affiliations